Senior Scientist - Phages

Drive the research in one of our phage programs!


Mehr Jobs von PhagoMed Biopharma GmbH
Siehe Firmendetails

Kontakt: Dr. Lorenzo Corsini
Email: corsini@phagomed.com

PhagoMed is looking for a HIGH-CALIBRE MICROBIOLOGY SCIENTIST TO JOIN OUR TEAM as Senior Phage Scientist (m/f/d) in Vienna, Austria

Do you want to be part of pioneering a high-profile antibiotics alternative and lead the research into breakthrough phage applications in areas of high medical need – together with a highly talented team and a network of leading physicians

Then apply for our current vacancy as

SENIOR SCIENTIST (m/f/d)

WHAT WE ARE LOOKING FOR

MANDATORY

  • PhD or equivalent in microbiology, phage biology or cell biology;
  • Excellent publication track record in a relevant field;
  • Highly structured thinking;
  • Interest in targeted pharmaceutical development;
  • Interest in working in a team of highly skilled and motivated professionals

WELCOME ADD-ON QUALIFICATIONS

  • Experience in research on antimicrobials, e.g. resistance formation, pharmacokinetics
  • Experience with bacterial biofilms
  • Experience in bacterial genetics
  • Experience in pharmaceutical research in a start-up/ company

ROLE DESCRIPTION

  • Establish research processes according to the latest microbiological technology developments (e.g. robotics and genomic data);
  • Further establish and validate potency model for phages against bacteria in biofilm models and planktonic growth;
  • Analyze the effect of phages on bacteria, including MIC, time-kill curves and other relevant parameters for antimicrobials, resistance formation, in planktonic growth and on biofilms
  • Further develop the PhagoMed phage breeding protocols to enhance selected properties of our target phages, e.g. lytic activity in biofilm and pharmacokinetics;
  • Evaluate immune response to phages;
  • Assembly of bacterial panels for species of interest, including in silico analysis of geno- and serotypes, to ensure required genetical and geographical breadth;
  • Establish standardized experimental protocols that will enable reproducibility in later GLP studies (e.g. potency, phage production and purification, phage evolution, effect on the immune system);
  • Documentation of results according to the PhagoMed Quality Standards (GLP-like), to ensure the quality of results and their documentation are acceptable to regulatory authorities, working towards a human clinical trial application;
  • Supervise research assistants, including training on working with bacteria, endolysins and phages, working in a BSL-2 environment, application of experimental and documentation standards;
  • Drafting of patent claims as appropriate, publication of selected results in scientific journals;

WHAT WE OFFER 

  • Become part of developing a new asset class in anti-infectives
  • Take full responsibility for key elements of the PhagoMed development plan
  • Pioneer new methods and processes to industrialize key research techniques
  • Be part of a highly motivated, multinational and fun team that believes phage-based therapies can be part of the solution to the global antibiotics crisis
  • A competitive compensation package that reflects the qualifications and seniority of the candidate. Due to legal requirements, we are required to state that the minimum salary for this job is a monthly salary of EUR 3.000,-- gross.

 

WHAT MOTIVATES US?

Phages have a natural ability to infect and lyse bacteria that is independent of antibiotics resistances. They also have highly desirable pharmaceutical properties: they are self-replicating and self-limiting, they have proven effectiveness against biofilms and have no known serious side effects. For many bacterial infections, natural, lytic phages are a promising alternative to antibiotics, but to this date no phage-based pharmaceuticals are on the market in either the US or the EU.

WHO AND WHAT IS PHAGOMED?

Who is PhagoMed

PhagoMed Biopharma GmbH is an Austrian biotech company focused on the development of human therapeutic applications of phages and phage-derived proteins. Currently, PhagoMed has three active development programs in the fields of periprosthetic joint infections, urinary tract infections and bacterial vaginosis. These development programs are based on the experiences of its clinical co-founders with last-resort treatments, as well as research collaborations with highly prestigious scientists and research institutions in Germany and Belgium. Since its incorporation in November 2017, the company has raised more than €5 million in private investments and public grants. PhagoMed has a team of eleven highly skilled scientist working on its programs, six of which at the Campus Vienna Biocenter in Vienna, Austria.

PhagoMed’s Vision

To SOLVE CHRONIC BACTERIAL INFECTIONS by developing specialized phage-based pharmaceuticals that can become FIRST LINE TREATMENT in our target indications.

 

INTERESTED? PLEASE CONTACT US!

To submit your application, please click on the following link:

Online-Application

 

Please also feel free to reach out directly if you have specific questions:

Dr. Lorenzo Corsini,

CEO | Research & Development, PhagoMed

corsini@phagomed.com

 


BEWERBEN

Bitte beziehen Sie sich bei Ihrer Bewerbung auf biotechjobs.at

ARBEITGEBER


MÖGLICHKEITEN ARBEITGEBER

PARTNER

KONTAKT

REGISTRIERUNG

JOBPLATTFORM


VISION

BILDUNG

FACEBOOK

BETREIBER


© EPIFRAME.COM

IMPRESSUM

WEITERE PLATTFORMEN


JOBCITY.AT

BIOTECHJOBS.AT

IT-KARRIERE.AT

BUSINESSJOBS.AT